Clinical trial
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or…
NCT00022633 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00022633 |
|---|---|
| Title | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract |
| Official title | Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in Patients Aged 70 Years or Older (and in a Cohort of Patients Younger Than 60 Years) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, paclitaxel |
| Enrollment | 65 |
| Start date | Jul 1, 2001 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 11, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: